Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05870943 · ClinicalTrials.gov registry record · NA

Hybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty Validation Study

A NA study of Obesity, sponsored by True You Weight Loss.

Active
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT05870943: Active NA study of Obesity, sponsored by True You Weight Loss.

NCT05870943 is a NA study of Obesity that is active but no longer recruiting, run by True You Weight Loss. The registered enrollment target is 48 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05870943, a NA study of Obesity, is active but no longer recruiting, sponsored by True You Weight Loss.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to evaluate the clinical safety, durability, and weight loss outcomes of the hybrid argon plasma coagulation + endoscopic sleeve gastroplasty (HAPC-ESG) procedure when compared to traditional endoscopic sleeve gastroplasty (ESG) alone. ESG was proven to be feasible in human subjects in 2013 and since then has become the most commonly performed endoscopic bariatric remodeling procedure. However, this procedure may be enhanced with the addition of the hybrid argon plasma coagulation (HAPC) technique, leading to enhanced weight loss, durability, and metabolic benefits. Argon plasma coagulation (APC) is a method of non-contact thermal hemostasis initially created to assist in inducing hemostasis utilizing a high-frequency current to the targeted area. This is a validation study of a pilot randomized control trial which will evaluate the safety, durability, and effects on weight loss of the combined HAPC-ESG approach when compared to traditional ESG alone.

Conditions Studied

Obesity

Interventions

  • PROCEDURE Endoscopic Sleeve Gastroplasty
  • PROCEDURE Hybrid Argon Plasma Coagulation

Study Locations (1)

North Carolina

  • True You Weight Loss - Cary

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2023-05-18
Est. Completion 2025-05
Phase NA

Sponsor

True You Weight Loss

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05870943

The ClinicalTrials.gov registry entry for NCT05870943 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower). The listed sponsor is True You Weight Loss, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Endoscopic Sleeve Gastroplasty is the first listed.

NCT05870943 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05870943 about?

NCT05870943 is a clinical study titled "Hybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty Validation Study". The purpose of this research is to evaluate the clinical safety, durability, and weight loss outcomes of the hybrid argon plasma coagulation + endoscopic sleeve gastroplasty (HAPC-ESG) procedure when compared to traditional endoscopic sleeve gastroplasty (ESG) alone. ESG was proven to be feasible in...

What is the current status of trial NCT05870943?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2023-05-18. Estimated completion is 2025-05.

What conditions does trial NCT05870943 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT05870943?

The interventions under investigation include: Endoscopic Sleeve Gastroplasty (PROCEDURE), Hybrid Argon Plasma Coagulation (PROCEDURE).

Who is sponsoring clinical trial NCT05870943?

This trial is sponsored by True You Weight Loss, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05870943 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obesity

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.